Australia provisionally approves AstraZeneca's COVID-19 vaccine as booster dose
Reading time 1 min Christian Fernsby ▼ | February 10, 2022On 8 February 2022, the medical regulator the Therapeutic Goods Administration (TGA) provisionally approved a booster dose of the AstraZeneca COVID-19 vaccine, Vaxzevria, for individuals aged 18 years and older.
Australia Greg Hunt
Topics: Australia
This means that the decision to receive Vaxzevria as a booster must be made in consultation with a medical professional. The mRNA COVID-19 vaccines (Comirnaty (Pfizer) or Spikevax (Moderna) are preferred as the booster dose in Australia, irrespective of the primary COVID-19 vaccine used. This includes for people who received the AstraZeneca COVID-19 vaccine for their primary course.
Minister for Health and Aged Care Greg Hunt said in a media release on Thursday that senior Australians in residential aged care are leading the national uptake of boosters, with 80.56 percent of those eligible for their third vaccine shot now having received it.
"The booster vaccination rate for aged care residents is well ahead of the national community figure of 55.43 percent," he said. ■